ConductScience.org, home

Paper42897352PubMed

NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling.

Raj ASWW and 4 others. J Mol Med (Berl), 2026.

Cite this record

ConductScience Library. NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling. Papers, record 42897352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42897352

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
NUAK isoforms promote glucose and glutamine metabolic reprogramming driven colon cancer progression and migration through regulation of AMPK/mTOR signaling.
Journal
J Mol Med (Berl)
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-05

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Raj ASWWAcily Skadon Worral Wilfred
2Babu JYMJaithanya Yesupogu Moorthy
3Sabanayagam RRajalakshmi
4Muthusami SSridhar
5Manoharan RRavihttps://orcid.org/0000-0002-3494-2173

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TOR Serine-Threonine KinasesMajor topic
GlucoseMajor topic
GlutamineMajor topic
Signal TransductionMajor topic
AMP-Activated Protein KinasesMajor topic
Protein KinasesMajor topic
Repressor ProteinsMajor topic
Colonic NeoplasmsMajor topic
Humans
Metabolic Reprogramming
Cell Movement
Cell Line, Tumor
Cell Proliferation
Disease Progression
Animals
Protein Serine-Threonine Kinases

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
EMDR/IRP/IG/15/2023-0000072Indian Council of Medical ResearchPubMed
KIIC/Incubatee/DST Ignition Grant/004/05/03/2024KIIC/DST Ignition GrantPubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123274086AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo.Cell Metab2013https://conductscience.org/library/papers/23274086PubMed
225037503The pentose phosphate pathway and cancer.Trends Biochem Sci2014https://conductscience.org/library/papers/25037503PubMed
336875093The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment.Front Immunol2023https://conductscience.org/library/papers/36875093PubMed
437852707Colorectal cancer: A health and economic problem.Best Pract Res Clin Gastroenterol2023https://conductscience.org/library/papers/37852707PubMed
538925848NUAK2 Inhibitors, KHKI-01128 and KHKI-01215, Exhibit Potent Anticancer Activity Against SW480 Colorectal Cancer Cells.Anticancer Res2024https://conductscience.org/library/papers/38925848PubMed
635192892MARK2/4 promotes Warburg effect and cell growth in non-small cell lung carcinoma through the AMPKα1/mTOR/HIF-1α signaling pathway.Biochim Biophys Acta Mol Cell Res2022https://conductscience.org/library/papers/35192892PubMed
731817676Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.Cells2019https://conductscience.org/library/papers/31817676PubMed
829500295Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress.Cancer Discov2018https://conductscience.org/library/papers/29500295PubMed
933367927Critical role of mTOR in regulating aerobic glycolysis in carcinogenesis (Review).Int J Oncol2021https://conductscience.org/library/papers/33367927PubMed
1039294640Altered metabolism in cancer: insights into energy pathways and therapeutic targets.Mol Cancer2024https://conductscience.org/library/papers/39294640PubMed
1137009798Targeting glutamine metabolism as a therapeutic strategy for cancer.Exp Mol Med2023https://conductscience.org/library/papers/37009798PubMed
1236978930Glutamine Starvation Affects Cell Cycle, Oxidative Homeostasis and Metabolism in Colorectal Cancer Cells.Antioxidants (Basel)2023https://conductscience.org/library/papers/36978930PubMed
1324838344Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.Mol Carcinog2015https://conductscience.org/library/papers/24838344PubMed
1433545220Distinctive role of SIK1 and SIK3 isoforms in aerobic glycolysis and cell growth of breast cancer through the regulation of p53 and mTOR signaling pathways.Biochim Biophys Acta Mol Cell Res2021https://conductscience.org/library/papers/33545220PubMed
1534243011Global colorectal cancer burden in 2020 and projections to 2040.Transl Oncol2021https://conductscience.org/library/papers/34243011PubMed
1626778478The Warburg Effect: How Does it Benefit Cancer Cells?Trends Biochem Sci2016https://conductscience.org/library/papers/26778478PubMed
1739965261NUAKs facilitate mTOR-mediated NSCLC proliferation and metastasis by modulating glucose metabolism and inhibiting p53 activity.Biochim Biophys Acta Mol Cell Res2025https://conductscience.org/library/papers/39965261PubMed
1840025169Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications.Exp Mol Med2025https://conductscience.org/library/papers/40025169PubMed
1929212303Targeting Glutamine Metabolism for Cancer Treatment.Biomol Ther (Seoul)2018https://conductscience.org/library/papers/29212303PubMed
2040598593Targeting glutamine metabolism as a potential target for cancer treatment.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40598593PubMed

See all 35 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42897352

GET https://conductscience.org/api/papers/v1/42897352/references?page=2